Management of life-threatening malignant central airway obstruction: A novel approach of using extracorporeal membrane oxygenation with tumor debulking and stenting
- PMID: 35965488
- PMCID: PMC9364020
- DOI: 10.1016/j.rmcr.2022.101718
Management of life-threatening malignant central airway obstruction: A novel approach of using extracorporeal membrane oxygenation with tumor debulking and stenting
Abstract
Extracorporeal membrane oxygenation (ECMO) is an artificial lung or heart used to oxygenate and circulate blood. Veno-venous ECMO is most commonly used as an emergency therapy in patients with acute respiratory distress syndrome (ARDS), but it has the potential to be useful in other respiratory-related diseases. We report a case where ECMO successfully allowed for interventional pulmonary procedures in a patient with life-threatening tracheal obstruction secondary to lung cancer, requiring tumor debulking and silicone Y stent placement. The patient was a 44-year-old male who was admitted to the intensive care unit (ICU) for an advanced stage subcarinal tumor invading into the trachea and bilateral main stem bronchi. The tumor was unresectable, and the first attempt to debulk the tumor was terminated due to the risk of complete airway occlusion. With the help of ECMO, the second attempt at tumor debulking was successful, and a Y stent was placed. The patient regained ventilation in both lungs and was transferred out of the ICU on day 2 post-op. The pathology confirmed squamous cell carcinoma, programmed death-ligand 1 (PD-L1) 99%. The patient received immunotherapy after hospital discharge. ECMO has the potential to be useful for patients with severe tracheal obstructions and compromised respiratory systems. For patients with certain types of lung cancer, who are good candidates for novel immunotherapies and targeted therapies, it offers a potential bridging therapy for procedures that would otherwise be too dangerous and should be considered when traditional treatments for these patients fail.
Keywords: Extracorporeal membrane oxygenation (ECMO); Immunotherapy; Malignant central airway obstruction; Tracheobronchial stent.
© 2022 The Author(s).
Conflict of interest statement
There are no conflicts of interest to disclose from the authors.
Figures






Similar articles
-
E Before A: Awake Bi-femoral Veno-Venous Extracorporeal Membrane Oxygenation as a Bridge to the Bifurcation Tracheal Y Stent.Cureus. 2025 Jan 4;17(1):e76890. doi: 10.7759/cureus.76890. eCollection 2025 Jan. Cureus. 2025. PMID: 39902016 Free PMC article.
-
Successful use of extracorporeal membrane oxygenation for airway-obstructing lung adenocarcinoma.Thorac Cancer. 2020 Oct;11(10):3024-3028. doi: 10.1111/1759-7714.13623. Epub 2020 Aug 26. Thorac Cancer. 2020. PMID: 32844533 Free PMC article.
-
Bronchoscopy-guided intervention therapy with extracorporeal membrane oxygenation support for advanced cancer metastasis to the central airway: A case report.Medicine (Baltimore). 2020 Mar;99(11):e19488. doi: 10.1097/MD.0000000000019488. Medicine (Baltimore). 2020. PMID: 32176086 Free PMC article.
-
[Extracorporeal Membrane Oxygenation in Complex Tracheobronchial Surgery: A Series Case Reports and Systematic Review].Zhongguo Fei Ai Za Zhi. 2024 Sep 20;27(9):717-724. doi: 10.3779/j.issn.1009-3419.2024.101.22. Zhongguo Fei Ai Za Zhi. 2024. PMID: 39492588 Free PMC article. Chinese.
-
The use of extracorporeal membrane oxygenation in the anticipated difficult airway: a case report and systematic review.Can J Anaesth. 2018 Jun;65(6):685-697. doi: 10.1007/s12630-018-1099-x. Epub 2018 Mar 1. Can J Anaesth. 2018. PMID: 29497994 English.
Cited by
-
Distal central airway obstruction: should preemptive extracorporeal membrane oxygenation be the standard of care?Anaesthesiol Intensive Ther. 2024;56(4):252-255. doi: 10.5114/ait.2024.145409. Anaesthesiol Intensive Ther. 2024. PMID: 39917972 Free PMC article. No abstract available.
-
E Before A: Awake Bi-femoral Veno-Venous Extracorporeal Membrane Oxygenation as a Bridge to the Bifurcation Tracheal Y Stent.Cureus. 2025 Jan 4;17(1):e76890. doi: 10.7759/cureus.76890. eCollection 2025 Jan. Cureus. 2025. PMID: 39902016 Free PMC article.
-
Management of malignancy-induced, life-threatening hypoxemic respiratory failure using a self-expanding Y stent.Respir Med Case Rep. 2022 Dec 29;42:101803. doi: 10.1016/j.rmcr.2022.101803. eCollection 2023. Respir Med Case Rep. 2022. PMID: 36685086 Free PMC article.
References
-
- Oberg C., Folch E., Santacruz J.F. Management of malignant airway obstruction. AME Medical Journal. 2018;3 https://amj.amegroups.com/article/view/4747
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous